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The protein A24 content of Ehrlich ascites tumor cells increased several-fold following treatment of cell 
cultures with nitrosoureas, but did not increase when other alkylating agents not containing carbamoyl 
moieties were tested. The same nitrosoureas and, in addition, Z-chloroethyl isocyanate inhibited an A24 
lyase-containing cytoplasm& extract in cleaving protein A24 into histone H2A and ubiquitin. It appears 
that carbamoylation of A24 lyase by nitrosoureas inhibits the enzyme and is responsible for the measured 
increases in cellular protein A24 content due to reduced turnover of this protein. 
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1. INTRODUCTION 
We have previously reported that the protein 
A24 (a conjugate of histone H2A and ubiquitin) 
content of Ehrlich ascites tumor cells increased 
several-fold following l-h treatments with either 
1-methyl-1-nitrosourea or 1,3-bis-(2-chloroethyl)- 
l-nitrosourea [l]. In that report we discussed the 
possibility that A24 lyase, the enzyme responsible 
for cleavage of protein A24, may be inhibited in 
nitrosourea-treated cells. We suggested that carba- 
moylation of the enzyme by nitrosourea degrada- 
tion products, notably isocyanates, would inac- 
tivate the enzyme and lead to increases in protein 
A24 due to the rapid formation of this protein [2]. 
The enzyme responsible for cleavage of protein 
A24 has been isolated and investigated by several 
groups [3-51. The enzyme cleaves the isopeptide 
linkage in protein A24 to release histone H2A and 
ubiquitin [3,5], and is found mostly in the 
cytoplasm of eukaryotic cells [3]. A24 lyase activi- 
ty appears to be responsible for the disappearance 
of protein A24 from chromatin of mitotic cells 
[2,6]. Reduced amounts of A24 have also been 
* To whom correspondence should be addressed 
observed following partial hepatectomy [7], 
following thioacetamide treatment [4,8], and in 
transcriptionally active rat liver chromatin [9]. 
In [l] we inferred that alkylating agents may be 
used as probes to study the function of A24 lyase. 
Here we report that only those alkylating agents 
containing a carbamoyl moiety affected A24 lyase 
activity measured either indirectly as increases in 
A24 content of drug-treated cells, or directly in 
cytoplasmic enzyme extracts. 
2. MATERIALS AND METHODS 
2.1. Cell culture and drug treatment 
Ehrlich ascites tumor cells adapted to suspension 
culture in Eagle’s minimum essential medium sup- 
plemented with 10% fetal calf serum were cultured 
as in [l]. 1 -Ethyl-l -nitrosourea (ENU) and 
1 -methyl-l nitrosourea (MNU) were purchased 
from Sigma, St. Louis, MO. 1,3-Bis-(2_chloro- 
ethyl)-1-nitrosourea (BCNU) was a gift from Dr 
Engle, Drug Research and Development Program, 
National Cancer Institute, National Institutes of 
Health, Bethesda, MD. Ethylmethanesulfonate 
(EMS) was a product of Koch-Light, Colnbrook, 
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England. Methylmethane-sulfonate (MMS) and 
2-chloroethyl isocyanate were from Eastman 
Kodak, Rochester, NY. Busulfan (1 &limethyl- 
sulfonyloxybutane) was a gift from the Wellcome 
Foundation, Burroughs Wellcome & Co., London, 
England. Drugs were dissolved in ethanol and 
stock solutions made in 0.9% NaCl. Further dilu- 
tions to appropriate drug concentrations were 
made either in culture medium or in A24 lyase in- 
cubation buffer. Drug treatment was for 1 h, 37°C 
for cells in culture. Nuclei from control or drug- 
treated cells were isolated by homogenization in 
hypotonic buffer and the remaining cytoplasm was 
removed with Triton X-100 [l]. Nuclear proteins 
were extracted in 0.4 N H2S04 and recovered by 
acetone precipitation. 
2.2. A24 lyase and reductive methylation of 
protein A24 
A cytoplasmic extract containing A24 lyase was 
prepared from Ehrlich ascites cells according to 
131. Protein A24 was isolated from calf thymus 
[lo] and purified by preparative polyacrylamide 
gel electrophoresis (PAGE) on acetic acid/urea 
gels. Reductive methylation of protein A24 was 
performed as in [11,12] using formaldehyde and 
NaB13H]& (Amersham). The radioactivity of A24 
was -130000 cpm/pg protein. The effect of 
alkylating agents on A24 lyase activity was deter- 
mined by preincubating the enzyme extract 25 min 
at 37°C with each drug before [3H]A24 was added. 
Incubation was then continued for 60 min, 37°C. 
The incubation buffer was 50 mM Tris-HCl, pH 
8.5, 2 mM mercaptoethanol, 1 mM phenylmethyl- 
sulfonyl fluoride [3]. The reaction was stopped by 
addition of SDS-PAGE sample buffer. Reaction 
products were analyzed on 15% SDS-PAGE as 
described below. 
2.3. Polyacrylamide gel electrophoresis 
Acid-extracted proteins were run on acetic 
acid/urea gels [ 131. The gels were subsequently 
stained with Coomassie blue and scanned at 
600 mn. The relative amounts of H2A, H2B, H3, 
H4 and protein A24 were determined by weighing 
the areas under each peak. To determine the effect 
of alkylating agents on A24 lyase activity, incuba- 
tion mixtures were separated on polyacrylamide- 
SDS gels in the Laemmli system [14]. 
3. RESULTS 
3.1. Protein A24 content of Ehrlich ascites cells 
tre?ted with alkylating agents 
Table 1 represents data on the effect of several 
different alkylating agents on the protein A24 con- 
tent of Ehrlich ascites cells following a l-h drug 
treatment. Drug concentrations used in these ex- 
periments were based on [l] and unpublished 
observations. As can be seen, increases in protein 
A24 appeared only in cells treated with 
nitrosoureas (MNU, ENU and BCNU) and with 
2-chloroethyl isocyanate (a BCNU decomposition 
product). 2-Chloroethyl isocyanate was chosen as 
a representative of nitrosourea decomposition pro- 
ducts possessing carbamoylating activity. Other 
alkylating agents (EMS, MMS and Busulfan) did 
not cause any change in the A24 content from that 
of control cells. In addition, nitrogen mustard 
(100 pg/ml) did not cause any increase in cellular 
A24 content [l]. As the acid-soluble proteins were 
Table 1 
Protein A24 content of Ehrlich ascites tumor cells 
following treatment with alkylating agents 
Alkylating 
agent 
Concentration 
@g/ml) during 
treatment 
(1 h, 37T) 
070 of control 
f SD 
None 
MNU 
ENU 
BCNU 
EMS 
MMS 
Busulfan 
2Chloroethyl 
100 
200 250 f 20 
u)o 2OO* 1s 
50 230 f 12 
200 lOO*lO 
200 100*10 
200 lOO*lO 
isocyanate 100 190 
(1 experiment) 
Suspension cultures of Ehrlich ascites tumor cells were 
treated for 1 h at 37°C with each of the indicated 
alkylating agents. Nuclei from control and drug-treated 
cells were isolated and the acid-soluble proteins 
extracted with 0.4 N H2m4. Proteins were separated in 
an acetic acid/urea PAGE system (10% gels [13]). 
Densitometric scans were made of Coomassie blue- 
stained gels and the ratio of protein A24 to core histones 
(H2A, H2B. H3, H4) was determined by weighing the 
areas under the protein peaks 
427 
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Fig. 1. Densitometric scans of fluorograms from separation of A24 iyase reaction products on polyacrylamide-SDS gels. 
Cytoplasmic A24 lyase enzyme extract (lOO-150rg total protein) was preincubated with nitrosoureas or 2-chloroethyl 
isocyanate (2-CNCO) for 25 min at 37°C in a total volume of 100-200 ~1. t3H]A24 (1 pg) was then added and 
incubation for cleavage of A24 to H2A and ubiquitin (Ub) was continued for 60 min at 37°C. The reaction was stopped 
by addition of polyacrylamide-SDS sample buffer. Samples were heated to lOO“C for 2 min and the entire incubation 
mixture was applied onto polyacrylamide-SDS gels [14]. The gels were subsequently treated with a fluorographic 
enhancer (EN’HANCE, New England Nuclear, Dreieich, FRG), dried under vacuum, and overlayed with Kodak X- 
Omat film. Exposure at -70°C was for 2 to 7 days. The developed films were scanned and the ratios of H2A/A24 
were determined by weighing the areas under each peak. % of control refers to comparison of H2A/A24 ratios for drug- 
treated samples relative to control values. TOP refers to the top of each gel. *TREATMENT is indicated as /cg 
nitrosoureas or isocyanate//cg total protein in incubation mixtures. 
extracted from nuclei immediately isolated from 
both control and drug-treated cells, the effect in- 
duced by l-h treatments with nitrosoureas 
represents quite rapid increases in cellular A24 
content. The results with nitrosoureas indicate that 
inhibition of an A24-degrading enzyme may be 
responsible for the increases in cellular A24. 
3.2. Effect of alkylating agents on A24 lyase 
activity 
A cytoplasmic extract containing A24 lyase ac- 
tivity which cleaved exogenous [‘HIA into 
radioactive H2A and ubiquitin was obtained from 
Ehrlich ascites cells. When the enzyme extract was 
preincubated with nitrosoureas before addition of 
[3H]A24, a dose-dependent inhibition of A24 lyase 
activity was found (fig.1). Protein A24 is 
stoichiometrically cleaved by A24 lyase into H2A 
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and ubiquitin [3], thus H2A + A24 content would 
be constant in each incubation mixture. Inhibition 
of A24 lyase would lead to a greater amount of 
A24 detected in the incubation mixture and thus 
lower H2A/A24 ratios. When compared to control 
values from the same experiment, the H2A/A24 
ratios would be a relative measure of A24 lyase ac- 
tivity. From fig.1, both MNU and BCNU are ef- 
fective inhibitors of A24 lyase. Treatment of an 
A24 lyase-containing cytoplasmic extract with 
either 3.1 pg MNU or 2.8 pg BCNU/~g total pro- 
tein for 60 min prior to addition of radioactive 
A24 resulted in 62 and 5 1% inhibition in cleavage 
of A24 to H2A + ubiquitin, respectively. Further 
increases in the BCNU concentration appeared to 
maximally inhibit A24 lyase activity, reaching a 
lower limit of approx. 30% of control values. The 
data in fig.1 also show that 2-chloroethyl iso- 
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cyanate is a strong inhibitor of A24 lyase. 
However, doubling the amount of 2-chloroethyl 
isocyanate from 2.5 to 5 pg/pg total protein did 
not further reduce A24 lyase activity to any extent. 
Different preparations of cytoplasmic A24 lyase 
extract yielded similar results within lo-25% of 
the values shown in fig.1. 
4. DISCUSSION 
Increases in protein A24 content of Ehrlich 
ascites tumor cells were observed following treat- 
ment with nitrosoureas or 2-chloroethyl iso- 
cyanate, but not following EMS, MMS or 
Busulfan treatment (table 1). As the drug treat- 
ment period was short (1 h), these results indicate 
a rapid formation of protein A24 in cells. The pro- 
tein A24 degrading enzyme, A24 lyase, appears to 
be inhibited in nitrosourea- and isocyanate-treated 
cell cultures. However, it is interesting to note that, 
although not presently isolated, a suspected A24 
ligase [3] responsible for forming A24 is not in- 
hibited by these drugs. Since the amino groups of 
lysine and arginine are primary sites of car- 
bamoylation by nitrosourea-derived isocyanates 
[15], A24 ligase may have few of these amino 
acids. 
Inhibition by nitrosoureas and isocyanates of 
A24 lyase activity was determined directly by a 
reduction in the formation of H2A (fig.1). 
Cytoplasmic enzyme extracts preincubated with 
MNU, BCNU or 2-chloroethyl isocyanate before 
addition of exogenous [3H]A24 were inhibited in 
degrading protein A24 in a dose-dependent 
manner. 
In order to exclude the possibility that 
nitrosoureas may activate specific protease activity 
which in itself could degrade A24 lyase and lead to 
reduced A24 cleavage, the protease inhibitor 
phenylmethylsulfonyl fluoride was included in the 
preparation of A24 lyase extract [3] and in the in- 
cubation mixtures containing A24 lyase extract 
and alkylating agents. The presence of a protease 
inhibitor did not alter the data presented in fig.1. 
Structure-activity relationships for the nitro- 
soureas indicate that alkylation reactions may be 
responsible for the therapeutic activity of these 
drugs while carbamoylation may be responsible for 
a portion of the toxic effect 115-171. Inhibition of 
essential enzymes uch as DNA polymerase by car- 
bamoylating products of nitrosourea decomposi- 
tion is known 118,191. 
Protein A24 is normally absent from cells in 
mitosis [2,6]. Condensation of chromatin would 
therefore be quite different with A24 residues pre- 
sent in nucleosomes of cells in which A24 lyase was 
inhibited. Even low doses of the nitrosoureas could 
inhibit A24 lyase to an extent such that local areas 
of chromatin contain the H2A-ubiquitin con- 
jugate. The effect this would have on both 
transcription and the mitotic process is unknown 
but may represent an additional toxic effect of 
nitrosoureas. 
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